EXEL 8-K 2026-01-12

EXELIXIS, INC. (EXEL) 8-K dated 2026-01-12 — accession 0000939767-26-000003. This URL is the filing, not the EXEL hub.

EXELIXIS, INC. (EXEL) is a biotechnology company listed on US.

EXELIXIS, INC. filed a 8-K on 2026-01-12. Accession 0000939767-26-000003.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported EXEL revenue for 2026-01-02 was $2.32B. Net income was $782.6M. Revenue was up 7.0% from 2025-01-03 to 2026-01-02. EXEL currently screens at market cap $12.69B.

Not investment advice. The EXEL SEC hub lists recent forms. The stock page is the research view.